Congress Answering Americans’ Call To Action On Drug Pricing
Feb 11, 2019
The momentum in Congress to act on out-of-control drug prices will continue to… Read More
© 2026 CSRXP- All Rights Reserved
Press & Statements
Family outraged over life-changing treatment going from free to $375,000 a year
Feb 7, 2019
NBC News Ben Kesslen February 7, 2019 “I don’t think I would be alive… Read More
Momentum Builds for Bipartisan CREATES Act
Feb 7, 2019
For Immediate Release Contact: Lauren Blair 201-213-5004 lblair@fp1strategies. Read More
CSRxP Statement On State Of The Union Address
Feb 6, 2019
For Immediate Release Contact: Lauren Blair 201-213-5004 [email protected]… Read More
SOTU: It’s Time To Come Together To Tackle Drug Prices
Feb 5, 2019
Tonight, Americans from across the country will tune-in to listen to the… Read More
CSRxP Leads Diverse Group Of Nearly 50 Organizations In Pledging Support For Bipartisan CREATES Act
Feb 5, 2019
Legislation Would Lower Prescription Drug Prices, Increase Competition,… Read More
CSRxP Statement on Trump Administration’s Latest Drug Pricing Proposal
Feb 1, 2019
For Immediate Release: Contact: Lauren Blair (201) 213-5004… Read More
Access To Drugs Is A Matter Of Life & Death, Mothers of Diabetic Children Testify Before Congress
Jan 30, 2019
At their first hearings of the 116th Congress, the Senate Finance and House… Read More
CSRxP Statement On House & Senate Committee Hearings On Skyrocketing Drug Prices
Jan 29, 2019
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
SHOT/CHASER: Pfizer & Novartis Double-Talk On Price Increases For Drugs Most Important To Bottom Lines
Jan 28, 2019
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
CSRxP Applauds CMS’s Commitment To Lower Drug Prices
Jan 25, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part III
Jan 25, 2019
In advance of the House and Senate hearings on January 29, 2019… Read More